All Stories

  1. The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism Diagnosis
  2. The economic value of rapid deployment aortic valve replacement via full sternotomy
  3. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population
  4. The economic value of INTUITY in aortic valve replacement
  5. Covariates of depression and high utilizers of healthcare: Impact on resource use and costs
  6. Cost comparison of radiofrequency catheter ablation versus cryoablation for atrial fibrillation in hospitals using both technologies
  7. Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis
  8. Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery
  9. The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
  10. Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study
  11. The Importance of Unresolved Fatigue in Depression: Costs and Comorbidities
  12. Clinical Characteristics and Unmet Need Among Real-World Atherosclerotic Cardiovascular Disease (ASCVD) Patients Stratified by Statin Use
  13. The impact of 5HT3RA antiemetics on the incidence of chemotherapy-induced nausea and vomiting (CINV), treatment adherence, and delay of therapy in early-stage breast cancer (BC) patients treated with moderately/highly emetogenic chemotherapy (MEC/HEC).
  14. Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
  15. Prevalence and predictors of human papillomavirus vaccination in adolescent girls
  16. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
  17. Relative Effect of HDL-C and Triglycerides on the Risk of Microvascular Complications Following Type II Diabetes
  18. Relative Impact of LDL-C and Non-HDL-C on the Risk of Microvascular Complications Following Type II Diabetes